FAM103A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.694210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.451600E-01
Normal-vs-Stage2
1.486970E-01
Normal-vs-Stage3
2.907000E-01
Normal-vs-Stage4
8.879800E-01
Stage1-vs-Stage2
5.524400E-01
Stage1-vs-Stage3
1.615430E-01
Stage1-vs-Stage4
9.528000E-01
Stage2-vs-Stage3
2.823000E-01
Stage2-vs-Stage4
6.764200E-01
Stage3-vs-Stage4
3.617200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.433610E-01
Normal-vs-AfricanAmerican
1.619580E-01
Normal-vs-Asian
7.837600E-01
Caucasian-vs-AfricanAmerican
4.946600E-01
Caucasian-vs-Asian
4.537600E-01
AfricanAmerican-vs-Asian
3.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.210170E-01
Normal-vs-Female
6.891200E-01
Male-vs-Female
4.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.510400E-01
Normal-vs-Age(41-60Yrs)
5.745800E-01
Normal-vs-Age(61-80Yrs)
4.971900E-02
Normal-vs-Age(81-100Yrs)
4.788800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.273200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.833600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.749600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.349700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.996800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.923200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.476600E-01
Normal-vs-Daily Drinker
1.128030E-02
Normal-vs-Weekly Drinker
6.825800E-02
Normal-vs-Occasional Drinker
2.691600E-01
Normal-vs-Social Drinker
1.120430E-01
Non Drinker-vs-Daily Drinker
7.732200E-02
Non Drinker-vs-Weekly Drinker
2.007800E-01
Non Drinker-vs-Occasional Drinker
3.903200E-01
Non Drinker-vs-Social Drinker
2.388400E-01
Daily Drinker-vs-Weekly Drinker
7.773600E-01
Daily Drinker-vs-Occasional Drinker
1.010300E-02
Daily Drinker-vs-Social Drinker
6.965800E-01
Weekly Drinker-vs-Occasional Drinker
3.650100E-02
Weekly Drinker-vs-Social Drinker
9.166800E-01
Occasional Drinker-vs-Social Drinker
5.112500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.265990E-01
Normal-vs-Grade 2
8.748000E-02
Normal-vs-Grade 3
1.095040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.040200E-01
Grade 1-vs-Grade 3
7.613000E-01
Grade 1-vs-Grade 4
1.265990E-01
Grade 2-vs-Grade 3
9.065800E-01
Grade 2-vs-Grade 4
8.748000E-02
Grade 3-vs-Grade 4
1.095040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.150200E-04
Normal-vs-NonDiabetic
7.935600E-01
Diabetic-vs-NonDiabetic
4.076900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.175800E-01
Normal-vs-NoPancreatitis
1.867220E-01
Pancreatitis-vs-NoPancreatitis
5.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.113600E-01
Normal-vs-N1
4.794600E-01
N0-vs-N1
6.181800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.269600E-01
Normal-vs-TP53-NonMutant
9.602200E-01
TP53-Mutant-vs-TP53-NonMutant
1.644230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
